Andrew D. RuskinPartnerK&L Gates LLPWebsitewww.klgates.comOrganization ProfileFull ProfileConnectEmailTwitterLinkedIn202-778-9415 Professional Biography Andrew Ruskin is a partner in the firm’s Washington, D.C. office. He is a member of the health care and FDA practice group. Areas of Focus Health Care and FDA Food, Drugs, Medical Devices, and Cosmetics (FDA) More Legal and Business Bylines From Andrew D. Ruskin 340B Update: Appellate Court Upholds 340B Payment Reduction as CMS Proposes Further Reductions for 2021 [Podcast] - (Posted On Thursday, August 13, 2020) 340B Update: Appeals Court Upholds 340B Payment Reduction Under the OPPS as CMS Proposes Further Reductions for CY 2021 - (Posted On Friday, August 07, 2020) Appellate Court's Reversal in AHA v. Azar Poses Existential Threat to Medicare Outpatient Prospective Payment System - (Posted On Thursday, July 30, 2020) President Trump Signs Drug Pricing Executive Orders Reinforcing the Administration's Priorities - (Posted On Monday, July 27, 2020) K&L Gates Triage: Recent Developments in the 340B Drug Pricing Program [Podcast] - (Posted On Thursday, July 23, 2020) 340b Update: HRSA Indicates It Lacks Authority to Enforce 340b Program Guidance - (Posted On Tuesday, July 21, 2020) Pagination Previous page ‹ Previous Page 3 Current Legal Analysis Detour Ahead: New Approach to Assessing Prior Art Rejections Under § 102(e) by: Benjamin N. Ediger, PhD Hatch-Waxman Litigation Expenses Are Deductible Under Internal Revenue Code § 162(a) by: Intellectual Property Practice Group Court Sides with RICO Complainant Who Received Tainted Medical Marijuana and with FDA on Regulating E-Cigarettes - SCOTUS Today by: Stuart M. Gerson The Clear and Unmistakable Standard for Applying Prosecution Disclaimer by: Sarah Mezini Using International Arbitration to Resolve Retaliatory Tariff Disputes in Global Supply Chains by: Frederick A. Acomb , James L. Woolard CSRD and CSDDD Officially Delayed, With Huge Majority of MEPs in Support by: John Verwey , Rachel E. Lowe Tempus Fugit Ad Nevada by: Keith Paul Bishop President Trump Announces "Reciprocal" Tariffs Beginning 5 April 2025 by: Nathaniel B. Bolin , David R. Allman Supreme Court Rules Lost Wages May Be Recoverable Under RICO For False Advertising After Drug Test Dismissal by: Bruce J. Douglas , Maria B. Shatonova Wyoming Bans Most Non-Compete Agreements by: Steven J Pearlman , Sehreen Ladak USCIS Announces Initial FY 2026 H-1B Cap Selection: What Employers Need to Do Next by: Jessica K. Lang SEC Provides Further Clarity in Rule 506(c) Offerings by: Daniel I. DeWolf , Samuel Asher Effron FedRAMP 20x – Major Overhaul Announced to Streamline the Security Authorization Process for Government Cloud Offerings by: Townsend L. Bourne , Daniel J. Alvarado USDA Will Fund 543 Projects in 29 States Through Higher Blends Infrastructure Incentive Program by: Lynn L. Bergeson , Carla N. Hutton Immigration Enforcement and Healthcare Facilities: Key Considerations for Providers by: Lotan Barbaresso , Amy J. Dilcher Upcoming Events Apr 30 2025 Workplace Horizons 2025 Apr 3 2025 Defense Counsel: Obligations to Insured Clients and Insurers Apr 3 2025 Defense Counsel: Obligations to Insured Clients and Insurers Apr 7 2025 Understanding the Basics of a Class Action Print
